A bill lawmakers assert is about "personal freedoms" strips pharmacists of the ability to deny certain medications for ...

Baynes to the Board and John Northcott as chief commercial officer Well capitalized with cash and marketable securities of $549.7 million SAN FRANCISCO, April 08, 2025 (GLOBE NEWSWIRE) -- Nurix ...

LITTLE ROCK — A House panel Wednesday approved a bill aimed at preventing pharmacy benefit managers ... of the House Insurance and Commerce Committee meeting, but a majority of the panel's ...

Support journalism that digs deeper into topics that matter most to Arkansans. Donate today to preserve the quality and integrity of local journalism. Support journalism that digs deeper into ...

HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...

The Massachusetts-based Lyndra Therapeutics Inc “is ceasing operations from March 26th, due to insufficient funding to continue their business activities,” said Sun Pharmaceutical Industries ...

The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by Jefferies on April 7, 2025. The analyst firm set a price target for $200.00 expecting AXSM to rise to within 12 months ...

About Perspective Therapeutics, Inc. Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body.